First Time Loading...

Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 113.2 CHF 0.18% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

MOVE Price Targets Summary
Medacta Group SA

Wall Street analysts forecast MOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOVE is 146.46 CHF with a low forecast of 131.3 CHF and a high forecast of 161.7 CHF.

Lowest
Price Target
131.3 CHF
16% Upside
Average
Price Target
146.46 CHF
29% Upside
Highest
Price Target
161.7 CHF
43% Upside
Medacta Group SA Competitors:
Price Targets
HOLX
Hologic Inc
15% Upside
DXCM
Dexcom Inc
22% Upside
METN
Metall Zug AG
59% Upside
RMD
Resmed Inc
0% Downside
NYXH
Nyxoah SA
66% Upside
PRN
Profound Medical Corp
63% Upside
122310
Genoray Co Ltd
500% Upside
NPCE
Neuropace Inc
33% Upside

Revenue
Forecast

Revenue Estimate
Medacta Group SA

For the last 6 years the compound annual growth rate for Medacta Group SA's revenue is 13%. The projected CAGR for the next 3 years is 14%.

13%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Medacta Group SA

For the last 6 years the compound annual growth rate for Medacta Group SA's operating income is 7%. The projected CAGR for the next 3 years is 19%.

7%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Medacta Group SA

For the last 6 years the compound annual growth rate for Medacta Group SA's net income is 6%. The projected CAGR for the next 3 years is 29%.

6%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOVE's stock price target?
Price Target
146.46 CHF

According to Wall Street analysts, the average 1-year price target for MOVE is 146.46 CHF with a low forecast of 131.3 CHF and a high forecast of 161.7 CHF.

What is Medacta Group SA's Revenue forecast?
Projected CAGR
14%

For the last 6 years the compound annual growth rate for Medacta Group SA's revenue is 13%. The projected CAGR for the next 3 years is 14%.

What is Medacta Group SA's Operating Income forecast?
Projected CAGR
19%

For the last 6 years the compound annual growth rate for Medacta Group SA's operating income is 7%. The projected CAGR for the next 3 years is 19%.

What is Medacta Group SA's Net Income forecast?
Projected CAGR
29%

For the last 6 years the compound annual growth rate for Medacta Group SA's net income is 6%. The projected CAGR for the next 3 years is 29%.